SCNI   $0.331  1.81% Market Closed After Close 0.321 -3.02%

Scinai Immunotherapeutics Ltd.
Total Cash 3.08M
totalCashPerShare 0.001
EBITDA -7.00M
Total Debt 20.82M
quickRatio 1.911
currentRatio 2.187
Total Revenue 284.00K
debtToEquity
Revenue/Share 0.555
ROA -0.28347
ROE
grossProfits
freeCashflow -3.79M
operatingCashflow -6.67M
earningsGrowth
revenueGrowth
grossMargins -0.57746
ebitdaMargins 0.0
operatingMargins -7.13732
profitMargins 0.0
enterpriseValue 11.94B
forwardPE
floatShares 2.92B
sharesOutstanding 853.00K
sharesShort 11.77K
sharesShortPriorMonth 11.81K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.13%
heldPercentInstitutions 0.04%
Short Ratio help_outline 0.21%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue -8.699
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -3.70M
trailingEps 0.0
forwardEps
enterpriseToEbitda -1.71K
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2024
institutionsCount 12
lastUpdated Nov. 2, 2024, 6:39 a.m.